Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text |  PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI:10.25259/IJMIO_30_2020 |
13,727 | 1,366 | 15,093 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_26_2020 |
12,058 | 736 | 12,794 |
Case ReportHyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young maleFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_16_2021 |
12,119 | 97 | 12,216 |
New Drug UpdateAmlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitorFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_13_2021 |
11,719 | 120 | 11,839 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December |
11,097 | 110 | 11,207 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI:10.25259/IJMIO_8_2022 |
9,043 | 2,081 | 11,124 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI:10.25259/IJMIO_5_2022 |
8,394 | 2,573 | 10,967 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI:10.25259/IJMIO_2_2022 |
8,843 | 2,016 | 10,859 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI:10.25259/IJMIO_1_2022 |
8,700 | 2,083 | 10,783 |
ErratumErratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)Full text | PDF Year: 2021, Volume: 6, Issue: 2, October DOI:10.25259/IJMIO_05_2020_ER |
10,364 | 72 | 10,436 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI:10.25259/IJMIO_26_2021 |
8,462 | 1,814 | 10,276 |
EditorialNanobytesFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI:10.25259/IJMIO_7_2019 |
5,429 | 4,714 | 10,143 |
Conference Review6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapiesFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_20_2021 |
9,836 | 170 | 10,006 |
Case SeriesDual driver in non-small cell lung carcinoma – therapeutic dilemmaFull text | PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI:10.25259/IJMIO_22_2021 |
9,789 | 197 | 9,986 |
Review ArticleThe evolving role of precision medicine in the management of advanced sarcomas – A mini reviewFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_6_2021 |
9,413 | 191 | 9,604 |
Review ArticleImmuno-oncology of differentiated thyroid cancerFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_36_2020 |
8,078 | 1,150 | 9,228 |
Review ArticleA compendium of population wide DNA methylation profile for oral cancer in IndiaFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI:10.25259/IJMIO_2_2021 |
7,755 | 1,384 | 9,139 |
Review ArticleImmuno-oncological era of breast cancer: A progressive path to better treatmentFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI:10.25259/IJMIO_3_2022 |
6,951 | 2,153 | 9,104 |
Brief CommentaryERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginningFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_10_2021 |
8,853 | 88 | 8,941 |
Case ReportUnusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemmaFull text | PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI:10.25259/IJMIO_18_2021 |
8,781 | 106 | 8,887 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_12_2021 |
8,708 | 124 | 8,832 |
Case ReportRedefining the treatment of metastatic uveal melanoma with immunotherapy – A case reportFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI:10.25259/IJMIO_11_2022 |
8,139 | 563 | 8,702 |
Brief CommentaryBioactive lipid: A novel diagnostic approach for retinoblastoma in clinical managementFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI:10.25259/IJMIO_7_2021 |
8,135 | 305 | 8,440 |
Original ArticleReal World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in IndiaFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI:10.25259/IJMIO_1_2019 |
3,960 | 3,965 | 7,925 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI:10.25259/IJMIO_21_2019 |
6,430 | 1,479 | 7,909 |
